References
[1] Sureshbabu A, Syed MA, Boddupalli CS, et al. Conditional overexpression of TGFβ1 promotes pulmonary inflammation, apoptosis and mortality via TGFβR2 in the developing mouse lung[J]. Respir Res, 2015, 16: 4.
[2] Bhandari V. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia[J]. Birth Defects Res A Clin Mol Teratol, 2014, 100(3): 189-201.
[3] Volonte D, Zou H, Bartholomew JN, et al. Oxidative stressinduced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6)[J]. J Biol Chem, 2015, 290(7): 4202-4214.
[4] Wang SJ, Zhao XH, Chen W, et al. Sirtuin 1 activation enhances the PGC-1α/mitochondrial antioxidant system pathway in status epilepticus[J]. Mol Med Rep, 2015, 11(1): 521-526.
[5] Nogueiras R, Habegger KM, Chaudhary N, et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism[J]. Physiol Rev, 2012, 92(3): 1479-1514.
[6] Meng C, Liu JL, Du AL. Cardioprotective effect of resveratrol on atherogenic diet-fed rats[J]. Int J Clin Exp Pathol, 2014, 7(11): 7899-7906.
[7] Sinclair DA, Guarente L. Small-molecule allosteric activators of sirtuins[J]. Annu Rev Pharmacol Toxicol, 2014, 54: 363-380.
[8] Ruan Y, Dong C, Patel J, et al. SIRT1 suppresses doxorubicininduced cardiotoxicity by regulating the oxidative stress and p38MAPK pathways[J]. Cell Physiol Biochem, 2015, 35(3): 1116-1124.
[9] Zhang L, Guo X, Xie W, et al. Resveratrol exerts an antiapoptotic effect on human bronchial epithelial cells undergoing cigarette smoke exposure[J]. Mol Med Rep, 2015, 11(3): 1752-1758.
[10] Li J, Feng L, Xing Y, et al. Radioprotective and antioxidant effect of resveratrol in hippocampus by activating Sirt1[J]. Int J Mol Sci, 2014, 15(4): 5928-5939.
[11] Nicoletti NF, Rodrigues-Junior V, Santos AA Jr, et al. Protective effects of resveratrol on hepatotoxicity induced by isoniazid and rifampicin via SIRT1 modulation[J]. J Nat Prod, 2014, 77(10): 2190-2195.
[12] Yun JM, Chien A, Jialal I, et al. Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights[J]. J Nutr Biochem, 2012, 23(7): 699-705.
[13] 车忠丽, 董文斌, 李清平, 等. PKCβ/P66Shc 氧化应激通路 在高氧诱导人肺泡上皮细胞活性氧簇产生中的作用[J]. 中国 当代儿科杂志, 2015, 17(3): 275-280.
[14] 张玲萍, 董文斌, 李清平, 等. p47phox 介导早产儿氧暴露后 体内活性氧簇产生的机制[J]. 中华实用儿科临床杂志, 2015, 30(2): 127-130.
[15] 卢美燕, 董文斌. 氧化应激在高体积分数氧肺损伤中的作用[J]. 实用儿科临床杂志, 2012, 27(22): 1763-1765.
[16] 张春艳, 董文斌, 李清平, 等. 白藜芦醇上调人肺泡上皮细 胞SIRT1 表达抑制高氧诱导的细胞凋亡[J]. 细胞与分子免疫 学杂志, 2015, 31(5): 590-595.
[17] 车忠丽, 董文斌, 李清平, 等. PKCβ/p66Shc 氧化应激通路 介导高氧诱导人肺泡上皮细胞凋亡的作用[J]. 临床儿科杂 志, 2013, 31(11): 1066-1069.
[18] Lau AW, Liu P, Inuzuka H, et al. SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation[J]. Am J Cancer Res, 2014, 4(3): 245-255.
[19] Iyer S, Han L, Bartell SM, et al. Sirtuin1 (Sirt1) promotes cortical bone formation by preventing β-catenin sequestration by FoxO transcription factors in osteoblast progenitors[J]. J Biol Chem, 2014, 289(35): 24069-24078.
[20] Hori YS, Kuno A, Hosoda R, et al. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress[J]. PLoS One, 2013, 8(9): e73875.
[21] Kim YH, Hwang JH, Kim KS, et al. NAD(P)H: quinone oxidoreductase 1 activation reduces blood pressure through regulation of endothelial nitric oxide synthase acetylation in spontaneously hypertensive rats[J]. Am J Hypertens, 2015, 28(1): 50-57.
[22] Tanno M, Sakamoto J, Miura T, et al. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1[J]. J Biol Chem, 2007, 282(9): 6823-6832.
[23] Morris KC, Lin HW, Thompson JW, et al. Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning[J]. J Cereb Blood Flow Metab, 2011, 31(4): 1003-1019.
[24] Verdin E, Dequiedt F, Kasler HG. Class II histone deacetylases: versatile regulators[J]. Trends Genet, 2003, 19(5): 286-293.